| Rank | Ticker | Price | Market Cap | Analyst Rating | Avg Volume |
|---|---|---|---|---|---|
#1 | INFQ | $15.66 | $2.7B | Strong Buy | $12.6M |
#2 | CVSA | $123.80 | $3.9B | Strong Buy | $260.9K |
#3 | MMED | $11.57 | $4.1B | Strong Buy | $585.9K |
#4 | KYIV | $14.55 | $3.1B | Strong Buy | $678.7K |
#5 | MDA | $45.62 | $4.8B | Strong Buy | $600.2K |
#6 | XNDU | $17.99 | $4.2B | Strong Buy | $7.0M |
#7 | LYFT | $13.70 | $5.2B | Buy | $14.5M |
#8 | KRG | $27.43 | $5.3B | Buy | $2.0M |
#9 | BXP | $60.91 | $9.4B | Buy | $1.5M |
#10 | VICR | $309.00 | $8.1B | Strong Buy | $813.5K |
#11 | TGTX | $39.34 | $6.0B | Strong Buy | $2.1M |
#12 | PARR | $58.72 | $2.9B | Buy | $1.3M |
#13 | MTRN | $221.39 | $2.6B | Buy | $262.3K |
#14 | SIG | $83.04 | $3.1B | Buy | $674.9K |
#15 | RSI | $26.84 | $2.9B | Strong Buy | $2.2M |
#16 | GEO | $22.76 | $2.5B | Strong Buy | $1.7M |
#17 | DBD | $77.92 | $3.0B | Strong Buy | $294.4K |
#18 | CARG | $27.90 | $2.6B | Buy | $1.3M |
#19 | IVT | $33.05 | $2.4B | Buy | $419.8K |
#20 | NFG | $80.10 | $7.8B | Buy | $891.4K |
#21 | WAY | $19.53 | $5.0B | Strong Buy | $2.6M |
#22 | SON | $49.68 | $4.9B | Buy | $1.2M |
#23 | SMG | $59.65 | $3.3B | Buy | $968.1K |
#24 | AZZ | $141.02 | $4.3B | Buy | $144.1K |
#25 | CSTM | $34.84 | $4.4B | Strong Buy | $2.0M |
#26 | TMDX | $69.75 | $2.2B | Buy | $1.8M |
#27 | BCRX | $8.51 | $2.3B | Strong Buy | $4.5M |
#28 | FAF | $68.29 | $7.2B | Strong Buy | $713.1K |
#29 | PAGP | $25.52 | $4.8B | Buy | $1.9M |
#30 | DUOL | $108.12 | $8.4B | Buy | $1.8M |
#31 | SHAK | $61.58 | $2.4B | Buy | $2.6M |
#32 | CALM | $75.23 | $3.7B | Buy | $663.4K |
#33 | MYRG | $462.58 | $3.9B | Buy | $300.5K |
#34 | FRSH | $9.10 | $2.4B | Buy | $10.0M |
#35 | RGEN | $116.01 | $6.6B | Buy | $1.3M |
#36 | CECO | $87.70 | $2.2B | Strong Buy | $837.2K |
#37 | PTCT | $67.74 | $5.7B | Buy | $1.4M |
#38 | DAN | $34.88 | $3.3B | Buy | $859.1K |
#39 | RELY | $21.22 | $4.5B | Buy | $5.5M |
#40 | GPOR | $175.85 | $3.5B | Buy | $270.8K |
#41 | NTNX | $46.54 | $9.1B | Buy | $3.2M |
#42 | QTWO | $45.58 | $2.9B | Buy | $945.5K |
#43 | KNSA | $52.99 | $3.5B | Strong Buy | $695.9K |
#44 | VIAV | $53.43 | $7.7B | Strong Buy | $6.5M |
#45 | PACS | $38.63 | $5.3B | Strong Buy | $867.5K |
#46 | ESE | $303.00 | $8.1B | Strong Buy | $270.6K |
#47 | FRPT | $51.16 | $2.4B | Buy | $1.7M |
#48 | LEVI | $22.71 | $9.0B | Strong Buy | $2.7M |
#49 | GBTG | $9.44 | $2.9B | Buy | $5.2M |
#50 | KD | $12.20 | $2.8B | Buy | $4.4M |
The FinQuota filters have identified what they believe to be the "Best Mid Cap Stocks to Buy (26 May 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.